About
About Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations for human and animal healthcare in India and internationally. It offers injectable critical care solutions, anti-infectives, antifungals, anti-ulcer therapies, oncology support, cardiovascular therapies, and women's healthcare solutions such as gonadotropins, hormonal therapies, and haematinic formulations. The company also develops pharmaceutical and nutritional solutions for livestock, poultry, equine, and companion animals. In addition, it engages in sterile injectable manufacturing, advanced lyophilization technology, liposomal drug delivery, quality assurance and quality control systems, and stability testing and validation services. The company offers its products in various forms, including lyophilized, liquid, and dry powder injections, as well as ointments, creams, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Research context
Lyka Labs Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Lyka Labs Limited is currently in a long term uptrend where the price is trading 74.6% above its 200 day moving average.
From a valuation standpoint, the stock is 74.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Lyka Labs Limited's total revenue rose by 46.1% to $268M since the same quarter in the previous year.
Its net income has increased by 94.5% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.8% to $35M since the same quarter in the previous year.
Based on the above factors, Lyka Labs Limited gets an overall score of 4/5.